Asset Details
Do you wish to reserve the book?
Potential Anti-Atherosclerotic Properties of Astaxanthin
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Potential Anti-Atherosclerotic Properties of Astaxanthin
Do you wish to request the book?
Potential Anti-Atherosclerotic Properties of Astaxanthin
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Potential Anti-Atherosclerotic Properties of Astaxanthin
2016
Overview
Astaxanthin is a naturally occurring red carotenoid pigment classified as a xanthophyll, found in microalgae and seafood such as salmon, trout, and shrimp. This review focuses on astaxanthin as a bioactive compound and outlines the evidence associated with its potential role in the prevention of atherosclerosis. Astaxanthin has a unique molecular structure that is responsible for its powerful antioxidant activities by quenching singlet oxygen and scavenging free radicals. Astaxanthin has been reported to inhibit low-density lipoprotein (LDL) oxidation and to increase high-density lipoprotein (HDL)-cholesterol and adiponectin levels in clinical studies. Accumulating evidence suggests that astaxanthin could exert preventive actions against atherosclerotic cardiovascular disease (CVD) via its potential to improve oxidative stress, inflammation, lipid metabolism, and glucose metabolism. In addition to identifying mechanisms of astaxanthin bioactivity by basic research, much more epidemiological and clinical evidence linking reduced CVD risk with dietary astaxanthin intake is needed.
Publisher
MDPI AG,MDPI
Subject
/ Animals
/ Antioxidants - administration & dosage
/ Antioxidants - isolation & purification
/ Atherosclerosis - prevention & control
/ Cardiovascular Diseases - pathology
/ Cardiovascular Diseases - prevention & control
/ Carotenoids - administration & dosage
/ Carotenoids - isolation & purification
/ Density
/ Humans
/ Lipids
/ Oxidative Stress - drug effects
/ Review
/ Salmon
/ Seafood
/ Seafoods
/ Xanthophylls - administration & dosage
